Mattias Carlsten

11PUBLICATIONS
24CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.

Panagiota Maravelia, Haidong Yao, Curtis Cai

|May 20, 2024
Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.

Laura Sanz-Ortega, Caroline Leijonhufvud, Lisanne Schoutens

|Jan 05, 2024
Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.

Laura Sanz-Ortega, Agneta Andersson, Mattias Carlsten

|Jul 26, 2023
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells.

Anna Palau, Filip Segerberg, Michael Lidschreiber

|Mar 16, 2022
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.

John Daly, Subhashis Sarkar, Alessandro Natoni

|Oct 11, 2021
LIR-1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody-dependent cellular cytotoxicity.

Caroline Leijonhufvud, Robert Reger, Filip Segerberg

Pageof 2

Frequent Collaborators

2 joint publications

Filip Segerberg

2 joint publications

Laura Sanz-Ortega

1 joint publications

Cynthia St Hilaire

1 joint publications

John Daly